Form 4: Wei Jiang Joins STAAR Surgical Board, Receives Stock and Restricted Stock Units

Wei Jiang was appointed to STAAR Surgical's Board of Directors and granted stock and restricted stock units as part of standard director compensation.

Summary

• Wei Jiang was appointed as a member of the Board of Directors of STAAR Surgical Co. on March 12, 2024.
• As a non-employee director, Mr. Jiang received 1,299 restricted shares of common stock.
• These shares represent a pro-rated amount of the standard director equity compensation for the 2023-2024 term.
• The restricted shares vest in full on the earlier of June 20, 2024, or the Corporation's 2024 Annual Meeting of Shareholders.
• Mr. Jiang also received 1,061 Restricted Stock Units (RSUs) as compensation for services as a director, electing to receive shares in lieu of cash compensation fees and deferring delivery of these shares.
• Each RSU represents the right to receive one share of the Corporation's common stock upon vesting.

Sentiment

Score: 7

Explanation: The document is a routine disclosure of a new board member's compensation, which is generally neutral to slightly positive as it indicates continued corporate governance.

Positives

• The appointment of Wei Jiang to the Board of Directors could bring valuable expertise and perspective to STAAR Surgical.
• The granting of stock and RSUs aligns Mr. Jiang's interests with those of the shareholders.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This announcement is typical for publicly traded companies when a new board member is appointed, disclosing the compensation package associated with the appointment.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment positively if they believe Mr. Jiang will contribute valuable expertise to the board.
• Employees are unlikely to be directly impacted by this appointment.

Key Dates